APC chieftain urges security agencies to end kidnappings of children

Alhaji Tijjani Tumsah, a former Interim National Secretary of the All Progressives Congress (APC) has urged security agencies to deplore all the required resources to put an end to kidnapping of innocent children for ransom.

Tumsah, in a statement made available to newsmen on Sunday in Abuja, expressed shock and sadness over the Friday abduction of hundreds of schoolgirls in Jangebe, Zamfara.

The APC chieftain said it was disturbing that the incident happened at a time that the Zamfara Government was pursuing peace deal with repentant bandits.

READ ALSO: PDP advices Bawa to restore professionalism in EFCC

He said the recurring incidence of school abductions and killings by bandits call for a multi-pronged approach to ending the insecurity ravaging the country.

He demanded immediate and safe release of the schoolgirls and those involved in the act should be made to face the full wrath of the law.

“The kidnapping of school children in their dormitories will, no doubt, negatively affect learning as no meaningful academic activities can take place in an unsecure environment.

“Attacks on schools may also discourage some parents from sending their kids to school and the consequence of having a generation without proper education can be best imagined than experienced,” he said.

The APC chieftain, therefore, urged the government at all levels to ensure that academic institutions are well secured to prevent attacks.

Vanguard News Nigeria

The post APC chieftain urges security agencies to end kidnappings of children appeared first on Vanguard News.

by Lawal Sherifat via Vanguard News https://ift.tt/3r5xI8K Best Known Member of the Cabinet Wikipedia

Comments

Effective Data Governance: IIM-Africa inks partnership deal with Data Management University

President/Chairman of the governing council of IIM-Africa, Dr. Oyedokun Oyewole has said that effective data governance strategy has become more essential for the survival and sustenance of government and businesses, especially with the sudden outbreak of COVID-19 Pandemic. Oyewole said there is the need to ensure that the right policies, processes, technology, and people are in place to effectively manage data while complying with legal and regulatory requirements. He said that as part of the IIM Africa’s commitments towards ensuring global best practices, it has entered into a long-term partnership with DataManagementU.com to bring the finest data management training to industries across Africa. READ ALSO: COVID-19: Foreign affairs minister says first set of Nigerians abroad to be evacuated soon According to the IIM President, the alliance is expected to provide members of the Institute and other professionals across Africa, high standards, internationally-recognized learn...

Naomi Osaka’s statement about withdrawing from French Open

Japan’s Naomi Osaka returns the ball to Romania’s Patricia Maria Tig during their first round match of the French open tennis tournament at the Roland Garros stadium Sunday, May 30, 2021 in Paris. (AP Photo/Christophe Ena) Naomi Osaka tweeted the following statement announcing her withdrawal from the French Open on Monday: “Hey everyone, this isn’t a situation I ever imagined or intended when I posted a few days ago. I think now the best thing for the tournament, the other players and my well-being is that I withdraw so that everyone can get back to focusing on the tennis going on in Paris. ”I never wanted to be a distraction and I accept that my timing was not idea and my message could have been clearer. ”More importantly I would never trivialize mental health or use the term lightly. The truth is that I have suffered long bouts of depression since the US Open in 2018 and I have had a really hard time coping with that. Anyone that knows me knows I’m introverted, and anyone tha...

Remdesivir: The COVID-19 drug helping patients recover faster

A vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States. PHOTO: AP Remdesivir has been shown to speed up recovery times for patients with COVID-19 in a major US-led trial, becoming the first drug with proven benefit against the disease. Here is what you need to know. – What is remdesivir? – Remdesivir is an experimental, broad spectrum antiviral made by US pharmaceutical Gilead Sciences that was first developed to treat Ebola, a viral hemorrhagic fever. It showed early promise in a primate study in 2016 and was later rolled out for a major trial in the Democratic Republic of Congo, where it was compared against three other medicines. That study concluded in 2019 when it was discontinued because it did not boost survival rates as greatly as two monoclonal antibody drugs, which are lab-engineered immune system proteins. In February, the US National Institute of Allergy and Infectious Diseases (NIAID) announced ...

Thorian

Search This Blog